Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Berger

Showing results (81-90 of 277) with videos related to

Pageof 28
Sort By:
Children (Basel, Switzerland)|October 26, 2024
The Pulmonary Artery Pulsatility Index Provides No Additional Prognostic Information in Pediatric Pulmonary Arterial HypertensionFaye E Smits, Chantal Lokhorst, Marlies G Haarman, et al.
Cardiovascular Diagnosis and Therapy|September 16, 2021
Hemodynamic and prognostic impact of the diastolic pulmonary arterial pressure in children with pulmonary arterial hypertension-a registry-based analysisChristian Apitz, Rolf M F Berger, D Dunbar Ivy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4B M Hall, L Fava, J Chen, et al.
International Journal of Cardiology|January 24, 2013
Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertensionJohannes M Douwes, Marcus T R Roofthooft, Beatrijs Bartelds, et al.
Circulation|June 28, 2006
Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled studyNazzareno Galiè, Maurice Beghetti, Michael A Gatzoulis, et al.
The Journal of Pediatrics|March 2, 2020
Serial Measurements of N-Terminal Pro-B-Type Natriuretic Peptide Serum Level for Monitoring Pulmonary Arterial Hypertension in ChildrenFatema Said, Meindina G Haarman, Marcus T R Roofthooft, et al.
Pacing and Clinical Electrophysiology : PACE|March 25, 2008
Drug management of fetal tachyarrhythmias: are we ready for a systematic and evidence-based approach?Freek van den Heuvel, Margreet T H E Bink-Boelkens, Gideon J du Marchie Sarvaas, et al.
International Journal of Cardiology|July 31, 2007
Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension studyMichael A Gatzoulis, Maurice Beghetti, Nazzareno Galiè, et al.
International Journal of Cardiology|May 26, 2009
Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysisRolf M F Berger, Maurice Beghetti, Nazzareno Galiè, et al.
Leukemia & Lymphoma|May 1, 1993
The role of Epstein-Barr virus subtypes in human immunodeficiency virus-associated lymphomaM J Boyle, T B Sculley, R Penny, et al.
Pageof 28

Showing results (81-90 of 277) with videos related to

Sort By:
Pageof 28
Children (Basel, Switzerland)|October 26, 2024
The Pulmonary Artery Pulsatility Index Provides No Additional Prognostic Information in Pediatric Pulmonary Arterial HypertensionFaye E Smits, Chantal Lokhorst, Marlies G Haarman, et al.
Cardiovascular Diagnosis and Therapy|September 16, 2021
Hemodynamic and prognostic impact of the diastolic pulmonary arterial pressure in children with pulmonary arterial hypertension-a registry-based analysisChristian Apitz, Rolf M F Berger, D Dunbar Ivy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4B M Hall, L Fava, J Chen, et al.
International Journal of Cardiology|January 24, 2013
Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertensionJohannes M Douwes, Marcus T R Roofthooft, Beatrijs Bartelds, et al.
Circulation|June 28, 2006
Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled studyNazzareno Galiè, Maurice Beghetti, Michael A Gatzoulis, et al.
The Journal of Pediatrics|March 2, 2020
Serial Measurements of N-Terminal Pro-B-Type Natriuretic Peptide Serum Level for Monitoring Pulmonary Arterial Hypertension in ChildrenFatema Said, Meindina G Haarman, Marcus T R Roofthooft, et al.
Pacing and Clinical Electrophysiology : PACE|March 25, 2008
Drug management of fetal tachyarrhythmias: are we ready for a systematic and evidence-based approach?Freek van den Heuvel, Margreet T H E Bink-Boelkens, Gideon J du Marchie Sarvaas, et al.
International Journal of Cardiology|July 31, 2007
Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension studyMichael A Gatzoulis, Maurice Beghetti, Nazzareno Galiè, et al.
International Journal of Cardiology|May 26, 2009
Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysisRolf M F Berger, Maurice Beghetti, Nazzareno Galiè, et al.
Leukemia & Lymphoma|May 1, 1993
The role of Epstein-Barr virus subtypes in human immunodeficiency virus-associated lymphomaM J Boyle, T B Sculley, R Penny, et al.
Pageof 28